Mortality News and Research

RSS

Study provides a key link between the social environment and healthy brains

As people age, maintaining a positive and predictable social environment becomes more and more important. For instance, keeping close ties with friends and family has been identified as one of the key ingredients to healthy aging.

24 Nov 2022

World Antimicrobial Awareness Week 2022: What is the burden of antimicrobial resistance?

As part of World Antimicrobial Resistance Week 2022, News-Medical speaks to Dr. Tomislav Meštrović about his new research discussing the burden of bacterial antimicrobial resistance in the WHO European region, as well as about how we can prevent antimicrobial resistance together.

24 Nov 2022

Exploring clinical characteristics and outcomes of hospitalized COVID-19 patients

Researchers described the clinical characteristics and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19) in the Netherlands.

24 Nov 2022

Do previously infected individuals still benefit from vaccination against COVID-19?

Researchers determined the vaccine effectiveness (VE) of the primary coronavirus disease 2019 (COVID-19) vaccination series.

24 Nov 2022

What was the impact of the COVID-19 pandemic on political unrest exacerbated by pandemic fatigue?

Researchers explored the impact of the coronavirus disease 2019 (COVID-19) pandemic on political unrest exacerbated by pandemic fatigue.

24 Nov 2022

Did the COVID-19 pandemic exacerbate existing racial discrepancies in the diagnosis of different cancers?

Researchers investigated whether disparities in the presentation of late-stage prostate, lung, colorectal, and breast cancers associated with race were exacerbated during the coronavirus disease 2019 (COVID-19) pandemic.

24 Nov 2022

Study highlights global estimates of mortality related to 33 clinically significant bacterial pathogens

Researchers presented comprehensive global estimates of the mortality burden related to 33 species or genera of bacterial pathogenic organisms causing 11 main infectious syndromes in 2019 using data and methods of the GBD 2019 and the global burden of antimicrobial resistance study conducted in the same year.

24 Nov 2022

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

Researchers assessed the association between receiving a prescription for Paxlovid and COVID-19-related hospitalization in the ensuing 30 days.

24 Nov 2022

COVID-19 disparities more likely to negatively impact Black and Hispanic men

More than two years into the pandemic, multiple analyses of federal, state and local data show that people of color were, and continue to be, disproportionately impacted by COVID-19.

23 Nov 2022

MiRNAs can be used as a biomarker to predict disease recurrence and mortality in breast cancer patients

Researchers at University of Galway have determined that biomarkers known as microRNAs can help predict which patients with breast cancer are likely to face a recurrence of the disease and death.

23 Nov 2022

Bivalent mRNA vaccines could enhance protective efficacy against COVID-19

A new study presents evidence suggestive of restored or increased efficacy from changing the formulation of COVID-19 vaccines to a bivalent one.

23 Nov 2022

Low-calorie sweetener does not seem to increase cancer risk in US adults

A recent study claims that the intake of low-calorie sweetener sweeteners does not increase the risk of cancer-related death. However, it may increase the risk of obesity and diabetes.

23 Nov 2022

Eating more foods with higher Food Compass scores lunked to better long-term health outcomes

The idea that what we eat directly affects our health is ancient; Hippocrates recognized this as far back as 400 B.C. But, identifying healthier foods in the supermarket aisle and on restaurant menus is increasingly challenging.

22 Nov 2022

Remdesivir appears to make a big difference in Japanese patients with COVID-19

The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines and treatments, although the efficacy of some remains controversial.

22 Nov 2022

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Researchers conducted a retrospective analysis to investigate the impact of vaccine-sharing strategies on the heterogenous global distribution of COVID-19 vaccines.

22 Nov 2022

The separate and combined associations of coffee and tea consumption with all-cause and cause-specific mortality

Researchers investigated the association between individual and combined coffee and tea consumption and all-cause and cause-specific mortality, such as those due to cardiovascular, respiratory, and digestive diseases.

22 Nov 2022

Survey: Two-thirds of European dietitians believe drinking coffee in moderation has clear health benefits

A new report by the European Federation of the Associations of Dietitians, supported by the Institute for Scientific Information on Coffee, has revealed that almost two-thirds (62%) of European dietitians believe drinking coffee in moderation has clear health benefits, with 86% agreeing that regular moderate intake can improve alertness and 69% agreeing that regular, moderate intake is associated with an improvement in overall sports performance.

22 Nov 2022

US experienced higher COVID-19 mortality during delta and omicron waves

A recent study estimates coronavirus disease 2019-related mortality and excess all-cause mortality in the US and 20 peer countries during the delta and omicron waves of infection.

22 Nov 2022

Stereotactic MRI-guided adaptive radiation therapy shows promise for treating pancreatic cancer

Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART.

21 Nov 2022

Study finds no benefits from angiotensin receptor blocker treatment for COVID-19

In a recent study published in the BMJ, researchers conducted a phase three, multicenter, randomized controlled trial to evaluate the effect of using angiotensin receptor blockers that disrupt the renin-angiotensin system on the clinical outcomes of individuals with coronavirus disease 2019 (COVID-19).

21 Nov 2022

Mortality News and Research

Study provides a key link between the social environment and healthy brains

World Antimicrobial Awareness Week 2022: What is the burden of antimicrobial resistance?

Exploring clinical characteristics and outcomes of hospitalized COVID-19 patients

Do previously infected individuals still benefit from vaccination against COVID-19?

What was the impact of the COVID-19 pandemic on political unrest exacerbated by pandemic fatigue?

Did the COVID-19 pandemic exacerbate existing racial discrepancies in the diagnosis of different cancers?

Study highlights global estimates of mortality related to 33 clinically significant bacterial pathogens

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

COVID-19 disparities more likely to negatively impact Black and Hispanic men

MiRNAs can be used as a biomarker to predict disease recurrence and mortality in breast cancer patients

Bivalent mRNA vaccines could enhance protective efficacy against COVID-19

Low-calorie sweetener does not seem to increase cancer risk in US adults

Eating more foods with higher Food Compass scores lunked to better long-term health outcomes

Remdesivir appears to make a big difference in Japanese patients with COVID-19

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

The separate and combined associations of coffee and tea consumption with all-cause and cause-specific mortality

Survey: Two-thirds of European dietitians believe drinking coffee in moderation has clear health benefits

US experienced higher COVID-19 mortality during delta and omicron waves

Stereotactic MRI-guided adaptive radiation therapy shows promise for treating pancreatic cancer

Study finds no benefits from angiotensin receptor blocker treatment for COVID-19

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News